In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole
- PMID: 10588320
- DOI: 10.1093/jac/44.4.553
In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole
Abstract
The MICs of amphotericin B and itraconazole for 230 isolates of Aspergillus spp., comprising 156 Aspergillus fumigatus, 20 Aspergillus terreus, 22 Aspergillus flavus, 17 Aspergillus nidulans and 15 Aspergillus niger, were determined by a broth microdilution method with RPMI 1640 medium. No isolate was detected with an MIC of amphotericin B >2 mg/L. Itraconazole MICs >16 mg/L were detected for four Aspergillus fumigatus and one Aspergillus nidulans isolates.
Similar articles
-
Susceptibility of Aspergillus strains from culture collections to amphotericin B and itraconazole.J Antimicrob Chemother. 1998 May;41(5):567-70. doi: 10.1093/jac/41.5.567. J Antimicrob Chemother. 1998. PMID: 9630411
-
Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.J Clin Microbiol. 2018 Sep 25;56(10):e00780-18. doi: 10.1128/JCM.00780-18. Print 2018 Oct. J Clin Microbiol. 2018. PMID: 30093391 Free PMC article.
-
In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp.Antimicrob Agents Chemother. 1998 Oct;42(10):2726-30. doi: 10.1128/AAC.42.10.2726. Antimicrob Agents Chemother. 1998. PMID: 9756785 Free PMC article.
-
Trends in the Prevalence of Amphotericin B-Resistance (AmBR) among Clinical Isolates of Aspergillus Species.J Mycol Med. 2022 Nov;32(4):101310. doi: 10.1016/j.mycmed.2022.101310. Epub 2022 Jul 14. J Mycol Med. 2022. PMID: 35907396 Review.
-
Antifungal susceptibility profile of cryptic species of Aspergillus.Mycopathologia. 2014 Dec;178(5-6):427-33. doi: 10.1007/s11046-014-9775-z. Epub 2014 Jun 28. Mycopathologia. 2014. PMID: 24972670 Review.
Cited by
-
Azole cross-resistance in Aspergillus fumigatus.Antimicrob Agents Chemother. 2002 Feb;46(2):556-7. doi: 10.1128/AAC.46.2.556-557.2002. Antimicrob Agents Chemother. 2002. PMID: 11796377 Free PMC article.
-
Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure.Emerg Infect Dis. 2009 Jul;15(7):1068-76. doi: 10.3201/eid1507.090043. Emerg Infect Dis. 2009. PMID: 19624922 Free PMC article.
-
Method for measuring postantifungal effect in Aspergillus species.Antimicrob Agents Chemother. 2002 Jun;46(6):1960-5. doi: 10.1128/AAC.46.6.1960-1965.2002. Antimicrob Agents Chemother. 2002. PMID: 12019115 Free PMC article.
-
Widespread amphotericin B-resistant strains of Aspergillus fumigatus in Hamilton, Canada.Infect Drug Resist. 2018 Sep 20;11:1549-1555. doi: 10.2147/IDR.S170952. eCollection 2018. Infect Drug Resist. 2018. PMID: 30288065 Free PMC article.
-
Mechanisms of triazole resistance in Aspergillus fumigatus.Environ Microbiol. 2020 Dec;22(12):4934-4952. doi: 10.1111/1462-2920.15274. Epub 2020 Oct 21. Environ Microbiol. 2020. PMID: 33047482 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous